Market research
RKDA Arcadia Biosciences Inc
NASDAQ USD Consumer Defensive
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 1M
- P/E ratio
- Not available
- Analyst target
- 12
- Dividend yield
- Not available
- Beta
- 0.55
Community
Investor discussion
1 comment
Sign in to join the RKDA discussion.
5 years, 4 months ago
Arcadia Biosciences, Inc is currently in a long term downtrend where the price is trading 8.0% below its 200 day moving average.
From a valuation standpoint, the stock is 65.4% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 3.4.
Arcadia Biosciences, Inc's total revenue rose by 1613.9% to $7M since the same quarter in the previous year.
Its net income has increased by 242.5% to $9M since the same quarter in the previous year.
Finally, its free cash flow fell by 25.6% to $-7M since the same quarter in the previous year.
Based on the above factors, Arcadia Biosciences, Inc gets an overall score of 3/5.